Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

AMBU-B.CO DK Equity

Ambu A/S
Nasdaq Copenhagen+ CompareTear sheet →
Health Care · FY ends Sep 30
DKK 75.05
-1.50 (-1.96%)
DKK · as of 2026-08-17 · marketstack
10 registered studies · 0 active

Studies where AMBU-B.CO is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.

7 interventional · 3 observational · 5 with posted results

government filings 180d: none disclosed

StudyPhaseStatusInterventionsConditionsEnrollmentPrimary completionUpdated
Observational Bronchoscopy Video Data Collection Study With Adult PatientsNCT06465797observationalNumber of bronchial segments accessed during bronchoscopyCompletedDiagnostic test: BronchoscopyLung Diseases, Lung Neoplasms, Lung Cancer, Lung Transplantation, Lung Diseases, Obstructive1152024-02-09actual2024-06-20
Procedural Efficiency and Organisational Impact of Rhino Laryngoscopes Procedures in ConsultsNCT05198219Pre-procedure time from notification of the physician to start of rhinolaryngoscopy.Randomized · Open-label · TreatmentNot applicableUnknown statusDevice: Ambu® aScope™ 4 Rhinolaryngo, Conventional reusable rhinolaryngoscopeLaryngeal Disease502022-04-302022-03-15
A Single-Use Duodenoscope in a Real-World SettingNCT04628949To evaluate the ERCP procedural success rates with the aScope™ Duodeno endoscope when completing the ERCP procedure for the intended indication(s).Open-label · TreatmentNot applicableCompletedDevice: aScope™ Duodeno endoscope and aBox™ DuodenoEndoscopic Retrograde Cholangiopancreatography (ERCP)2482022-01-27actual2022-08-01
Single-use Cystoscope System for Direct Visualization of the Urethra and BladderNCT04190641performance of Ambu® aScope™ 4 Cysto and aView™ UrologiaOpen-label · DiagnosticNot applicableCompletedDevice: Ambu aScope 4 Cysto and aView UrologiaCystoscope, Bladder Cancer, Lower Urinary Tract Symptoms42021-04-30actual2021-10-14
Evaluation of Performance and Safety of Ambu® aScope™ 4 Cysto and aView™ Urologia for Flexible CystoscopyNCT04192474Performance of the cystoscopeOpen-label · OtherNot applicableCompletedDevice: Flexible cystoscopyCystoscope, Lower Urinary Tract Symptoms, Bladder Disease832021-04-07actual2021-10-14
AuraOnce Performance ObservationNCT04128527results2021-11-03observationalNumber of Participants With Leakage Observed During ProcedureStudy Protocol and Statistical Analysis PlanCompletedDevice: Placement of laryngeal maskAnesthesia162019-11-05actual2021-11-03
Study on Adhesion Properties of Three Different AdhesivesNCT04125797results2026-07-22Number of Participants Who Achieved Adhesion Success After 72 HoursOpen-label · Basic scienceStudy Protocol and Statistical Analysis PlanNot applicableCompletedOther: Application of adhesiveHealthy392019-10-31actual2026-07-22
Double-lumen Tubes (DLT) - Health Economic StudyNCT03817879results2020-02-13Number of Times Bronchoscope is UsedRandomized · Single-masked · Health services researchStudy Protocol and Statistical Analysis PlanNot applicableCompletedProcedure: VivaSight double-lumen tube for single-lung ventilation, Conventional double-lument tube for single-lung ventilationSingle Lung Ventilation, Thoracic Surgery, Anesthesia, Cost-effectiveness702019-01-31actual2020-02-13
Evaluation of BAL Procedure With Ambu aScope 3 Large in Patients in an ICU SettingNCT03581474results2020-02-13Improvement in Oxygenation (PaO2/FiO2 Ratio) After a BAL TreatmentOpen-label · TreatmentStudy Protocol and Statistical Analysis PlanNot applicableTerminatedsponsor's stated reason: Slow recruitmentDevice: Bronchoscopic procedureAtelectasis, Bronchoscopy122018-07-03actual2020-02-13
Prospective Non-interventional Evaluation of Intubation and Intensive Care Use of the New aScope™ 4 Broncho and aViewNCT03294213results2021-03-03observationalUser Preference of ScopeStudy Protocol and Statistical Analysis PlanCompletedDevice: aScope 4 BronchoBronchoscopy, Anesthesia1762018-01-31actual2021-03-03

Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.

Source: ClinicalTrials.gov, retrieved 2026-08-19